Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes
- 1 January 1984
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 4 (1) , 40-44
- https://doi.org/10.1007/bf00915286
Abstract
A precipitating antigen-antibody system has been characterized that occurs in patients with polymyositis. At least half of the patients not only have polymyositis but also have scleroderma. The proposed name for this antigen found in calf thymus extract (CTE) is PM-Scl, to indicate the almost universal presence of polymyositis and the frequent occurrence of scleroderma in the patients who make antibodies to this antigen. The antigen is probably nucleolar since all sera which precipitate with the PM-Scl antigen stain the nucleoli of Hep2 cells by indirect immunofluorescence. The PM-Scl immune system is a distinctive one different from the other known precipitins that occur in patients with polymyositis and dermatomyositis including Jo1, nRNP, and Mi. This PM-Scl antigen and its antibody represent one system which constitutes part of the reactions previously designated as PM1. Interlaboratory exchange of sera and extracts have established the unique nature of this reaction which occurs in patients with inflammatory myopathy.This publication has 8 references indexed in Scilit:
- Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap.Journal of Clinical Investigation, 1981
- Antibodies to nuclear antigens in polymyositis: relationship to autoimmune ‘overlap syndromes’ and carcinoma.Annals of the Rheumatic Diseases, 1981
- Purification and characterization of a nuclear non-histone basic protein (Mi-1) which reacts with anti-immunoglobulin sera and the sera of patients with dermatomyositisMolecular Immunology, 1980
- Heterogeneity of precipitating antibodies in polymyositis and dermatomyositisArthritis & Rheumatism, 1980
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Antinuclear antibody with distinct specificity for polymyositis.Journal of Clinical Investigation, 1977
- Description of a serological reaction characteristic of polymyositisClinical Immunology and Immunopathology, 1976
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975